Table 3 Sensitivity and specificity of MMP9 and MMP3 for early and advanced stages of bladder cancer patients
A. (MMP9) | ||
|---|---|---|
Stage/parameter % | Sensitivity | Specificity |
Early stages | 27.28 | 100 |
Advanced stages | 97.3 | 100 |
Total | 64.29 | 100 |
B. (MMP3) | ||
Stage/parameter % | Sensitivity | Specificity |
Early stages | 84.85 | 91.67 |
Advanced stages | 89.19 | 100 |
Total | 86.42 | 92.31 |